ab种植体(Neoss与Osstell合作推出NeoTell种植体稳定性测量设备)

本文由口腔器械知识站提供

标签：#dental

Neoss集团最近推出了NeoTellTM，这是一款尖端设备，旨在快速准确地测量植入物的稳定性。

Neoss Group recently unveiled NeoTellTM, a cutting-edge device designed to quickly and accurately measure implant stability.

这项创新是Neoss集团最近与全球种植体稳定性测量和骨整合进展监测领导者Osstell AB合作的第一个成果。

This innovation is the first result of Neoss Group's recent partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring.

NeoTell是一款价格合理的植入物稳定性测试解决方案，它使用共振频率分析（RFA）技术为被测试植入物的稳定性提供客观评分。然后，该评分可用于教育患者了解他们的治疗进展，并告知临床医生装载植入物进行临时或永久修复的最佳时机。

Designed as an affordable implant stability testing solution, NeoTell uses Resonance Frequency Analysis (RFA) technology to provide an objective score for the stability of the implant being tested. This score can then be used to both educate patients about their treatment progress and to inform clinicians on the best timing for loading implants with temporary or permanent restorations.

RFA植入物稳定性分析并不是一项新技术，因为Osstell多年来一直在开发和研究RFA装置。这项循证技术已在1300多项研究中得到验证。

RFA implant stability analysis is not a new technology, as Osstell has developed and studied RFA devices for years. The evidence-based technology has been validated in more than 1300 studies.

“NeoTell将为临床医生提供更高效、更有效的工作方式。我们与Osstell的合作确保了我们能够为牙科社区提供一个全面的解决方案，提高牙科植入手术的可预测性和成功率。我们相信NeoTell将会成为牙科专业人员不可或缺的工具，”DDS的Robert Gottlander说，Neoss集团总裁兼首席执行官在一份新闻稿中表示。

"NeoTell will offer clinicians the means to work more efficiently and effectively. Our collaboration with Osstell ensures that we can provide the dental community with a comprehensive solution that enhances the predictability and success of dental implant procedures. We believe that NeoTell will become an indispensable tool for dental professionals," says Robert Gottlander, DDS, president and CEO of the Neoss Group in a press release.

NeoTell被描述为直观且用户友好，并且它不需要任何侵入性程序来向临床医生提供植入物稳定性数据。稳定性测试提供的信息据说有助于推动知情的治疗决策，并提高护理标准。

NeoTell is described as intuitive and user-friendly, and it does not require any invasive procedures to deliver implant stability data to clinicians. The information provided by the stability testing is said to help drive informed treatment decisions and raise the standard of care.

该系统与一次性使用的SmartPegsTM配合使用，SmartPegsTM经过设计和校准以匹配特定的牙科植入系统。无菌交付后，将栓钉连接到植入物上，然后NeoTell设备使用RFA技术分析植入物并提供植入物稳定性商评分。

The system works in conjunction with single-use SmartPegsTM which are designed and calibrated to match specific dental implant systems. Delivered sterile, the pegs are connected the implant and the NeoTell device then uses the RFA technology to analyze the implant and deliver an Implant Stability Quotient score.

当与Neoss Group的NeossONE植入系统一起使用时，NeoTell更加方便。由于植入系统在多个植入物设计中仅使用单个假体平台，因此只有一种SmartPeg类型可与70多种不同的Neoss植入物兼容。

When used with Neoss Group’s NeossONE implant system, the NeoTell is even more convenient. With the implant system using just a single prosthetic platform across multiple implant designs, just one SmartPeg type is compatible with more than 70 different Neoss implants.

患者将从这一进步中受益匪浅，因为NeoTell的精确评估能力能够实现更准确的治疗计划。这有助于增强患者对牙科植入程序的信心和满意度，最终改善结果。

Patients are set to benefit significantly from this advancement, as NeoTell's precise assessment capabilities enable more accurate treatment planning. This can help build greater patient confidence and satisfaction with their dental implant procedures, ultimately leading to improved outcomes.

本文内容来源于政府渠道，由【口腔器械知识站】整理